how long is an open vial of semaglutide good for Compounded Women Semaglutide / Cyanocobalamin Injection |

While no longer in short supply meaning that compounding should no longer be possible some companies have continued to provide the drug to patients under exceptions for 'personalised' treatments under a framework known as Section 503A

Saxenda and Wegovy are injectable medications approved by the Food and Drug Administration (FDA) for the treatment of obesity and obesity-related health conditions

Some operate in states with less stringent oversight

Hypothyroidism is not a contraindication to Wegovy provided thyroid function is adequately managed with levothyroxine replacement

This means it gradually reduces in concentration over that period